Agoracom Blog Home

Posts Tagged ‘Marijuana’

« Older Entries
Newer Entries »

CLIENT FEATURE: Empower Clinics With 165,000 Patients Already, $CBDT.ca Is Positioned To Become A Medical #Cannabis & #CBD Retail Killer $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 4:30 PM on Wednesday, November 13th, 2019

Why Empower Clinics?

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $4MM USD in revenue annually (2019)
  • Q3 2019 preliminary unaudited revenue saw a year over year growth of approximately 138%
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Launching CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025

 The Team

 The Products

  • Commenced selling its proprietary line of CBD-based products called SOLLIEVO
  • Empower’s patient base and customers are expected to benefit from access to high margin derivative products, including CBD lotion, tinctures, spectrum oils, capsules, lozenges, patches, e-drinks, topical lotions, gel caps, hemp extract drops and pet elixir hemp extract drops.
  • Patients and customers will be able to access Empower’s home delivery and e-commerce platform.

CBD Extraction

  • Opening first CBD Extraction facility in Portland, OR.
  • 5,000 sq. ft. leased building with first extraction system capable of producing 20kg per day of 99% spectrum oil, isolate or distillate
  • Current wholesale pricing is $6,500 USD per kg with annual capacity of 6,000kg an estimated $39MM USD revenue.
  • Facility can scale to four extraction systems for up to 24,000kg of product and over $150MM USD revenue

FULL DISCLOSURE: Empower Clinics is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , , ,
Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on CLIENT FEATURE: Empower Clinics With 165,000 Patients Already, $CBDT.ca Is Positioned To Become A Medical #Cannabis & #CBD Retail Killer $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

NORTHBUD $NBUD.ca – The #CBD Industry Flourishes After Overcoming Certain Legal Barriers $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:34 AM on Wednesday, November 13th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.


—————————–

The CBD Industry Flourishes After Overcoming Certain Legal Barriers

  • Total sales for the U.S. hemp industry totaled USD 820 Million in 2017
  • The research also suggests that the industry is expected to grow to USD 1.9 Billion by 2022 and at a CAGR of 14.4% during the 5-year period.

NEW YORK, Nov. 13, 2019 – Humans have been using hemp for centuries prior to its disappearance from the public eye. Decades ago, hemp was predominantly being used to manufacture textiles, paper, construction materials, and fuel. However, now, hemp is most commonly known for being a derivative of the cannabis plant, which has caused it to be classified as a drug under international regulations.

Furthermore, most people associate cannabis with its marijuana derivative, which imparts cerebral-altering effects on its users. However, hemp and marijuana are two completely different plants in terms of their biological makeup. Hemp contains much more CBD, or cannabidiol, while marijuana contains a significant amount of THC, or tetrahydrocannabinol. In fact, CBD and THC are just two of at least 113 cannabinoids identified in the cannabis plant. However, THC is one of the only three cannabinoids scheduled by the UN Convention on Psychotropic Substances. Originally, the UN listed THC as a Schedule 1 substance in 1971 but reclassified it to Schedule 2 in 1991 after a recommendation by the World Health Organization (WHO).

However, under the Single Convention on Narcotic Drugs, THC is classified as both a Schedule 1 and Schedule 4 drug. And while the debate over legalizing THC is often a tense topic for most countries, CBD legalization appears to be a more popular direction of discourse. In recent times, CBD has become widely popular because of the therapeutic benefits it offers without causing psychoactive effects on the consumer. Notably, researchers highlighted that CBD can be used to treat minor conditions such as headaches or even severe symptoms associated with cancer. Nevertheless, international health agencies have all agreed that more research is required in order to move forward with approving CBD as a medicinal treatment.

But regardless, a number of countries such as Canada and the U.S. already moved to completely legalize the use of CBD. And according to data compiled by Hemp Business Journal, a division of New Frontier Data, the total sales for the U.S. hemp industry totaled USD 820 Million in 2017. The research also suggests that the industry is expected to grow to USD 1.9 Billion by 2022 and at a CAGR of 14.4% during the 5-year period.

In 2017, the U.S. hemp market was primarily driven by hemp-derived CBD products. At the time, hemp-derived CBD products accounted for 23% of the total market share, delivering USD 190 Million in sales. Personal care products accounted for 22% of the market share, narrowly lagging behind hemp-derived CBD products. However, by 2022, Hemp Business Journal expects the hemp-derived CBD market to takeoff. The hemp-derived CBD sector is forecast to deliver USD 646 Million in sales. Furthermore, the research suggests that the personal care products segment is expected to witness its market share diminishes as industrial applications fill the gap. And as legal barriers are removed and consumer education continues to spread, the hemp industry is positioned to witness exponential growth.

Furthermore, many researchers are actively pushing legislators and lawmakers to reconsider the scheduling of cannabis because of rich therapeutic benefits. For instance, researchers from the University of Minnesota’s (U of M) College of Biological Sciences and College of Food, Agricultural, and Natural Resource Sciences are one of a handful of groups that are federally authorized to study cannabis. The researchers have argued they have “indisputable evidence” that hemp and marijuana should be separated, according to Mercola. “It’s a plant of major economic importance that is very poorly understood scientifically… With this study, we have indisputable evidence for a genetic basis of differences among cannabis varieties, further challenging the position that all cannabis should be regulated as a drug,” said George Weiblen, a professor with a joint appointment in the U of M’s College of Biological Sciences and College of Food, Agricultural and Natural Resource Sciences.

Source: https://www.prnewswire.com/news-releases/the-cbd-industry-flourishes-after-overcoming-certain-legal-barriers-300957483.html

Tags: , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – The #CBD Industry Flourishes After Overcoming Certain Legal Barriers $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

NORTHBUD $NBUD.ca – 5 Reasons Why Everyone Is Obsessed With #CBD Gummies $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:38 AM on Tuesday, November 12th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

5 Reasons Why Everyone Is Obsessed With CBD Gummies

By Jerrard Jonson

If you’ve heard any of the hype lately about CBD and CBD gummies, you’re probably thinking, “what’s all the fuss about?” With last year’s introduction of the Farm Bill, the CBD industry has skyrocketed beyond anyone’s expectations, creating countless products infused with the cannabinoid CBD. With numerous health benefits, availability and affordability, CBD products are making quite the scene in a new(er) industry. Here are five reasons why everyone is obsessed with CBD gummies.

Availability

CBD gummies are pretty much everywhere at this point. You can get them online, in your drug store, in holistic health shops, and more. With such wide availability, it’s no wonder these tasty treats are a favorite among consumers of CBD. That being said, it’s important to note that not all CBD gummies are the same.

The quality of the CBD used in them can have a profound effect on the effectiveness, so it’s always better to purchase from a provider with a good reputation for quality. Companies like Verma Farms offer some of the highest-quality CBD gummies on the market.

Be sure to check the CBD availability and legality in your state. While hemp may be legal on the federal level, individual states still have the ability to regulate and even ban hemp and CBD products.

Longer-Lasting Effects

Img source: kushiebites.com

Since CBD gummies are ingested, the effects of the CBD tend to last longer than if it were inhaled or taken under the tongue. The slow process of digestion means that your CBD might take an hour or longer to kick in, but once it does, you can expect the effect to last for at least a few hours.

The longer-lasting effects of the gummies are mostly what drives consumers to make these a favorite. They also taste pretty good too! Straight CBD oil taken under the tongue can leave a plant aftertaste, which can be quite unpleasant. Chewing a gummy eliminates this unpleasantness by coating the CBD with a tasty, sugary gummy.

Consumers feel like gummies give them a bit more bang for their buck since some CBD products can be quite pricey. With longer-lasting effects, you’ll need less throughout the day to achieve the desired effect; making them an affordable and effective way to enjoy CBD.

CBD’s Benefits

Let’s take a moment to talk about some of the great effects that CBD has on the body. From reducing stress and anxiety to improved sleep, the effects of CBD are numerous and positive. While the research is still pretty much in its infancy, what we do know is that CBD so far hasn’t shown any major negative side-effects.

CBD is different from THC, though they’re both found in the cannabis plant. THC creates the euphoric “high” that marijuana is known for, whereas CBD is much the opposite. Instead of euphoria, users have said that they feel clarity and calm. It’s even been said that CBD can help reduce the effects of THC for when you’ve had a little too much

People all over the world are using CBD oils and gummies for joint aches, concentration, treating anxiety, and all manner of health ailments. Some users swear by CBD as a cure-all, but science has yet to discover the true spectrum of benefits offered by this amazing compound.

Affordability

Img source: kushiebites.com

While CBD oils and vape pens can be a bit costly, CBD gummies remain on the affordable end of the spectrum, and, as stated above, their long-lasting effects makes them much more cost-efficient than their inhaled or absorbed counterparts. We’ve seen hundreds of brands pop up over the course of the last year, and as the industry grows, we’re certain to see more. Right now, CBD demand is high, so prices will probably remain at about the same level for the coming years.

Easy to Take

Probably the best thing about CBD gummies is that they’re easy to take. Whether you’re 21 or 71, chewing them is simple and the digestive process does all of the work for you. Where vape pens and oils can require different processes for maximum effectiveness, with this product, you simply chew and swallow and wait.

This makes gummies accessible to people of all ages, backgrounds, and ailments. The availability and versatility of these awesome products are what have made them an absolute favorite among CBD users nationwide.

Conclusion

Img source: whio.com

Whether you’re new to CBD or a seasoned veteran, you’ll want to give CBD gummies a try to see why everyone’s raving about them. From being easy to take to having longer-lasting effects, they can offer a unique CBD product that you’ll find is both simple and affordable.

Source: https://www.chartattack.com/5-reasons-why-everyone-is-obsessed-with-cbd-gummies/

Tags: , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – 5 Reasons Why Everyone Is Obsessed With #CBD Gummies $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

PRIMO Nutraceuticals $PRMO.ca Signs a Lease Agreement with Aqua Farming Tech Inc., of Southern California to Grow 20 Acres of Certified Organic Hemp $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:24 AM on Tuesday, November 12th, 2019
  • Signed a lease agreement with Aqua Farming Tech, Inc. (Aqua Farming Tech) to grow certified organic sun-grown hemp on an aggregate 20 acre plot of land from Aqua Farming Tech‘s southern California property located near Palm Springs

VANCOUVER, British Columbia, Nov. 12, 2019  — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”)is pleased to announce that it has signed a lease agreement with Aqua Farming Tech, Inc. (Aqua Farming Tech) to grow certified organic sun-grown hemp on an aggregate 20 acre plot of land from Aqua Farming Tech‘s southern California property located near Palm Springs.

About Aqua Farming Tech Inc.

Aqua Farming Tech has been farming Tilapia in the Coachella Valley Since 1993, conducted from two farms encompassing 120 acres located in Southern California, making them the leader in sustainability produced premium quality aquaculture (Telapia), agriculture (Moringa) and premium brands in the health and wellness industry.  

With two decades of experience in “Aqua” farming technology and excellent distribution relationships in Los Angeles, San Francisco and San Diego markets, the Company’s core business is the production of sustainability raised Tilapia (Aquaculture) and Moringa (Agriculture) on a farm located in California’s prolific Coachella Valley 150 miles from Los Angeles.

Aqua Farming tech has been at the forefront of developing and implementing the most advanced, sustainable, ecologically sound methods of producing clean, quality seafood in California. Aqua Farming tech was the first farm with more than 60 cement tanks built above ground, the first farm to utilize a mechanical aerator to improve the oxygenation of its water, the first farm to develop and implement a method of recycling its water, the first farm to generate a significant percentage of its power from solar power and the first farm to manufacture its own feed.   

Primo’s Self-Sufficient and Sustainable way to grow Hemp All Year Round

Primo intends to leverage Aqua Farming Tech’s success in aquaculture and agriculture by utilizing its already established resource and infrastructure in place. Primo will be able to capitalize on the sustainable features of the Aqua Farming Tech operations which include:

  • Any electricity used will be generated by solar power
  • The 20 Acre plot has a water drip system already in place located in the N.E corner of the 120 acre farm
  • Nutrient dense “fish feed” comes from algae and moringa organically grown on site
  • The water used to raise the fish is re-circulated through ponds that contain plants which clean the water for re-use
  • The nutrient rich fish pond water used to irrigate the moringa crops will also be used to water the 20 acre hemp farm
  • This in-turn will make our product “Certified Organic Hemp”

This lease agreement combines Primo’s hemp growing experience in Oregon and the prime California outdoor cultivation location will allow the company to grow all year round with the potential to harvest three crops a year using Aqua Farming Tech’s Self-Sufficient Sustainable growing technology in aquaculture and agriculture operations.

President, Andy Jagpal Comments:

“We’ve been seeking to enter the California cannabis market for some time now. California is the leader in cannabis consumption and finding the right partner to work with is a critical first step. We are so lucky to be working alongside an industry leader like Aqua Farming Tech. By leveraging Aqua Farming Tech self-sustaining infrastructure and resources allows our Company to enter this massive California market with little to less start-up capital required if we were to do it alone. The end result of this relationship will be to produce a CBD oil sold as Certified Organic.”

Primo expects to produce over 25,000 lbs of dried hemp biomass from the 20 acre parcel per harvest three times per year. Future phases of the lease agreement will explore the potential of further expanding the outdoor hemp production beyond the current 20-acre site, through the option of another 80 acre site nearby in Coachella Valley California. The execution of all phases will allow Primo to develop into a large outdoor organic hemp cultivator in California State.

About Primo Nutraceuticals, Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo provides fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. In addition to the Company’s flagship hemp project in Oregon State and the Greenhouse campus in Washington State, Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

Andy Jagpal, President and Director

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/primo-nutraceuticals, as well as on the company’s site.

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816.

http://primoceuticals.com/
https://twitter.com/prmonutra
www.thriveCBD.org

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/42ffb0f1-f39d-4bc2-9a08-bfc2f39819c8

Aerial View of 120 Acre Farm

Aerial View of 120 Acre Farm

Tags: , , , , , ,
Posted in PRIMO Nutraceuticals Inc. | Comments Off on PRIMO Nutraceuticals $PRMO.ca Signs a Lease Agreement with Aqua Farming Tech Inc., of Southern California to Grow 20 Acres of Certified Organic Hemp $CROP.ca $VP.ca NF.ca $MCOA

NORTHBUD $NBUD.ca – Top 10 #Marijuana Industry News Stories $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 2:44 PM on Monday, November 11th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

Top 10 Marijuana Industry News Stories

Cannabis Countdown: Top 10 Marijuana Industry News Stories of the Week

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana industry news stories for the week of November 4th – 10th, 2019.

Without further ado, let’s get started.

10. Drake’s Next Act: “Potline Bling” Feat. Canopy Growth Corp

Multi-Platinum Recording Superstar Drake and Canopy Growth Announce New Cannabis Partnership

Drake is heading home and will own a majority stake in Toronto-based “More Life Growth”. Canopy Growth (TSX: WEED) (NYSE: CGC) will own the remaining 40% in the new fully licensed cannabis producer.

READ FULL DRAKE ARTICLE

9. Passengers Carrying Cannabis on Air Canada’s Toronto to Vancouver Flight Shocked When Plane Got Re-Routed to U.S.

Foggy Conditions Forced Flight AC 125 to Land at Seattle Airport with Some Passengers Carrying Cannabis and CBD

One legal expert gives advice to Canadians on how to handle an extraordinary situation like this.

READ FULL AIR CANADA ARTICLE

8. Mexico Has Until April 30 to Legalize Cannabis, Supreme Court Rules

That Legislation Proposed Rules Limiting Foreign Ownership, Vertical Integration and License Resale

Mexico’s Supreme Court gave Congress another six months to approve legislation that legalizes all forms of cannabis, postponing until the end of April the deadline for when the Latin American country would create the world’s largest adult-use market by population.

READ FULL MEXICO ARTICLE

7. Canopy Growth Downsizes Latin America Workforce as Region Struggles to Generate Revenue

Investors Have Sent a Clear Message They Want Companies to be More Prudent in Their Spending

One of the largest cannabis companies in the world, Canopy Growth (TSX: WEED) (NYSE: CGC), is restructuring its overseas operations by laying off 15% of its workforce in Latin America, reflecting the slow pace at which revenue-generating opportunities and regulatory structures are evolving in the region.

READ FULL CANOPY GROWTH ARTICLE

6. FDA Won’t be Hurried to Create CBD Exceptions Amid Safety Concerns

The Agency’s Biggest Concern is Whether CBD is Safe to Consume in Food and Supplements

A top official for the U.S. Food and Drug Administration (FDA) said the agency is concerned that developing a legal exception for supplements containing CBD could send the wrong message, both to companies interested in entering the market and consumers.

READ FULL FDA CBD ARTICLE

5. Ontario Business Group Wants ‘Clear Timeline’ for Cannabis Store Expansion

So Far, Ontario Has Used a Botched Lottery System to Award Licenses to Open Recreational Marijuana Stores

A group comprised of cannabis industry leaders and experts is calling on Ontario’s government to provide a more complete timetable for when retail stores will be permitted through an open allocation of licenses.

READ FULL ONTARIO ARTICLE

4. Michigan Nets 52 Adult-Use Marijuana Applications on First Day

State Regulators Expect the First License to be Issued Before the End of November

Marijuana regulators in Michigan received 52 recreational cannabis business license applications on the first day of the application period.

READ FULL MICHIGAN ARTICLE

3. Cannabis Canada: Pot Industry Added Nearly Billion to GDP in August

Cannabis Sales in Canada Expected to Double Next Year to $3.16 Billion

Canaccord Genuity cannabis analyst Matt Bottomley expects revenue in Canada’s legal pot sector to more than double next year despite slower-than-expected growth. Bottomley said in a research note to clients that Canada’s cannabis industry should expect $3.16 billion in revenue in 2020, up from the $1.46 billion forecast for 2019.

READ FULL CANADA STATS ARTICLE

2. U.S. Senate Approves Legislation Protecting State-Legal Medical Cannabis Programs from Federal Interference

Supporters Hope Similar Protection for Recreational States Will Be Included in Final Version Sent to President Trump

The U.S. Senate passed a spending bill extending a provision that protects medical cannabis states from federal interference. It’s unknown if the broader House approved protections for adult-use state cannabis programs will be included in the final version of the bill that’s passed along to President Trump.

READ FULL MMJ SENATE ARTICLE

1. Breakthrough in CDC Vape Crisis Investigation

Vitamin E Acetate Linked to THC May Be to Blame

Vitamin E acetate, an additive sometimes used in THC and other vaping products, may be to blame for a national vape crisis of e-cigarette-related lung injuries that’s linked to dozens of deaths, according to U.S. Centers for Disease Control and Prevention officials.

Source: https://finance.yahoo.com/news/cannabis-countdown-top-10-marijuana-141349361.html

Tags: , , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Top 10 #Marijuana Industry News Stories $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

PRIMO Nutraceuticals Inc. $PRMO.ca – Top 5 Benefits of #CBD Oil $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:23 AM on Monday, November 11th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Top 5 Benefits of CBD Oil

  • Did you know that there are more than 100 chemical elements present in the cannabis plant, with CDB oil being only one of them?
  • This oil has not only proven to be an effective treatment for insomnia, stress and other medical conditions, it also helps improve mental health.

By Guest Contributor

CBD has been found to be an effective treatment option for multiple physical and psychological conditions. But, before you start, here are a few benefits you should know.

Did you know that there are more than 100 chemical elements present in the cannabis plant, with CDB oil being only one of them? This oil has not only proven to be an effective treatment for insomnia, stress and other medical conditions, it also helps improve mental health.

The best part is that although found in the cannabis plant, it does have any intoxicating properties and is safe for use by anyone.

However, it is important to buy CBD oil, glass bong bowls and other devices only from the best online smoke shop, says BomDiggidy, a leading provider of a wide range of CBD infused products, including body butter, lip balm, soap and roll-ons.

1.      Reduces Anxiety and Depression

According to the Anxiety and Depression Association of America, 6% of Americans are affected by depression and 18% by anxiety. CBD oil has proven to be one of the best cures for these mental health issues. Serotonin is a natural mood enhancer, released in the brain, and the usage of the oil can help regulate and stabilize this process.

A study published in the Journal of Psychopharmacology revealed that an oral dose of 400mg could help alleviate depression and social anxiety. It also helps the brain minimize and control the breakdown of Anandamide, the “bliss” element. This, in turn, improves the mental state to a great extent.

2.      CBD and  Cancer

Research shows that non-psychoactive CBD oils have anti-cancer properties. In fact, it can even help kill cancer cells in humans and prevent them from spreading across the body. Apart from this, many side effects of chemotherapy and other cancer treatments, such as nausea, pain, vomiting and so on are relieved or prevented.

3.      Helps Improve Sleep

CBD improves the quality of sleep for people with arthritis and Parkinson’s disease. Since it is a good cure for a number of other discomforts, such as pain, stress, anxiety and so on, it automatically induces sleep by taking care of the discomfort.

4.      Cures Skin Conditions

CBD has been also proven to improve skin conditions like acne, by fighting inflammation. It is widely being used in creams and lotions to help clear breakouts by reducing sebum production. CBD oil also has antioxidant properties, which fight wrinkles, dullness and other signs of aging skin. It also works great for people with sensitive skin because of its soothing properties, which minimize redness and other types of irritation.

5.      Helps Ease Chronic Pain

When taken in a moderate amount, under the tongue, CBD oils can help in curing chronic pain and inflammation in the human body, including multiple sclerosis and arthritis. This is done by influencing the endocannabinoid receptor activity and affecting the neurotransmitters. It also minimizes surgical and nerve pain.

Source: https://southfloridareporter.com/top-5-benefits-of-cbd-oil/

Tags: , , , , , ,
Posted in All Recent Posts, Bougainville Ventures | Comments Off on PRIMO Nutraceuticals Inc. $PRMO.ca – Top 5 Benefits of #CBD Oil $CROP.ca $VP.ca NF.ca $MCOA

New Report Says #CBD Sales Could Surpass $1B In 2019, $10B By 2024 SPONSOR: Empower Clinics $CBDT $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 10:47 AM on Thursday, November 7th, 2019

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics
  • Patient database of over 165,000 patients 
  • Platform generating $4MM USD in revenue annually (2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Launching CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.

————————-

New Report Says CBD Sales Could Surpass $1B In 2019, $10B By 2024

Javier Hasse

A new report produced by the editors of Hemp Industry Daily says retail sales of CBD in the United States are on track to surpassing $1 billion in 2019. This would imply 133% growth over 2018 sales.

Even more interestingly, the newly released 2019 Hemp & CBD Industry Factbook says CBD retail sales in the U.S. may eclipse $10 billion by 2024.

“The recent surge of consumer demand for CBD, coupled with increasingly easy access to CBD products, is expected to drive retail sales to about $1.1 billion-$1.3 billion in 2019,” said Kristen Nichols, editor of the Second Annual Hemp & CBD Industry Factbook. “We project retail CBD sales will increase to $10.3 billion by 2024, a five-year compound annual growth rate of 54%.”

Seeking to fill the gap left by the lack of federal agencies tracking hemp as a commodity, the 2019 Annual Hemp & CBD Industry Factbook seeks to provide understanding of the current and future challenges needed to make the most accurate and informed business decisions. Research-driven insights, will help business professionals understand economic, agricultural and regulatory developments impacting their positions and growth in the industry.

“Imagine running a race with brand-new shoes and a burst of energy but no idea what the course looks like. That’s somewhat the position in which today’s hempy industry finds itself,” Nichols said. “Relying on deeply researched data points along the way could make the difference between hitting the finish line and running off course.”

Source: https://www.benzinga.com/markets/cannabis/19/10/14614694/new-report-says-cbd-sales-could-surpass-1b-in-2019-10b-by-2024

Tags: , , , , , ,
Posted in All Recent Posts, Empower Clinics Inc., Featured | Comments Off on New Report Says #CBD Sales Could Surpass $1B In 2019, $10B By 2024 SPONSOR: Empower Clinics $CBDT $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Empower Clinics $CBDT.ca Announces Record Preliminary Unaudited Q3 2019 Revenue with 138% year over year increase and Details for Release of Financial Statements $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:25 AM on Thursday, November 7th, 2019
  • Empowers’ Q3 2019 preliminary unaudited revenue saw a year over year growth of approximately 138%
  • Company’s Q3 preliminary total direct clinic expenses have been reduced by approximately 40% even with the addition of the six Sun Valley clinic locations.
  • Company also has patient visits in corporate clinics increase by triple digits, with October 2019 patients seen increasing by 336% to 1,847 versus October 2018 with 550 patients seen.       
  • Earnings results are set to be released on November 14, 2019 at 9:00 am Eastern Time

VANCOUVER, Nov. 7, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, a multi-state operator of medical health & wellness clinics, a CBD product producer and operator of an extraction facility in Oregon, is pleased to announce preliminary unaudited year over year revenue growth of 138% for the three months ended September 30, 2019. The company also decreased total direct clinic expenses by approximately 40%, while adding six new clinics as a result of the Sun Valley clinics acquisition.

The Company also has patient visits in corporate clinics increase by triple digits, with October 2019 patients seen increasing by 336% to 1,847 versus October 2018 with 550 patients seen.       

“The Company is starting to feel the positive impact that the Sun Valley clinics acquisition has provided with their strong operational performance in Arizona, in conjunction with continued cost cutting measures with operations in Oregon and Washington State,” said Steven McAuley, CEO of Empower. “We have also been able to integrate key back office, admin, payroll & human resource functions from the Pacific Northwest into the operational controls of Sun Valley, bringing improved productivity to the organization.”

As part of the Company’s continued expansion of our health & wellness clinic model, we have already set up retail CBD product sales in-clinic, and now we have launched expanded physician based services starting with key Arizona clinics.

New Modalities and Services

  • Physician’s CBD Enhanced Massage, Acupuncture, or Cupping Sessions

  • CBD-Cannabis-Supplement Consumption & Coaching Consultation

  • Introduction to Alternative Health and Cannabinoid Therapies by a Physician

  • Comprehensive Naturopathic Patient Analysis & Consultation

  • Dietary Antigen Testing, Physician Consultation/Action Plan, & Concierge Blood Draw

  • Neurotransmitter (urine) Profile & Physician Consultation/Action Plan

  • Spectracell Micronutrient Test & Physician Consultation/Action Plan

Empower plans to release its third quarter results ending September 30th, 2019 on November 14, 2019 at 9:00AM Eastern time.

Financial Measures

This news release makes reference to certain non-IFRS measures, including certain industry metrics. These metrics and measures are not recognized measures under IFRS do not have meanings prescribed under IFRS and are as a result unlikely to be comparable to similar measures presented by other companies. These measures are provided as information complimentary to those IFRS measures by providing a further understanding of our operating results from the perspective of management. As such, these measures should not be considered in isolation or in lieu of review of our financial information reported under IFRS. These non-IFRS measures, including the industry measures, are used to provide investors with supplementary measures of our operating performance that may not otherwise be apparent when relying solely on IFRS metrics.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2019/07/c9142.html

Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019

Tags: , , , , , , ,
Posted in All Recent Posts, Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Announces Record Preliminary Unaudited Q3 2019 Revenue with 138% year over year increase and Details for Release of Financial Statements $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

North Bud Farms $NBUD.ca Announces Annual General and Special Meeting on December 16th and the Closing of the First Tranche of its Non-Brokered Private Placement of Secured Convertible Debenture Units $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:50 PM on Wednesday, November 6th, 2019
  • Annual General and Special Meeting at 1:00 p.m. on Monday, December 16, 2019 at the office of McMillan LLP World Exchange Plaza, Suite 2000, Ottawa, Ontario.  
  • Announce that on November 6, 2019, the board authorized the issuance of up to 4,000 convertible debenture units of the Company at a price of $1,000 per Unit for total gross proceeds of up to $4,000,000.

TORONTO, Nov. 06, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) today announces that the Company will hold its Annual General and Special Meeting at 1:00 p.m. on Monday, December 16, 2019 at the office of McMillan LLP World Exchange Plaza, Suite 2000, Ottawa, Ontario.  

Additionally, the Company is pleased to announce that on November 6, 2019, the board authorized the issuance of up to 4,000 convertible debenture units (“Units”) of the Company at a price of $1,000 per Unit for total gross proceeds of up to $4,000,000. Based on this decision the Company will not be closing any additional tranches of the previously announced equity private placement.

Each Unit is comprised of one $1,000 principal amount of secured convertible debenture (a “Convertible Debenture”) accruing interest at 10.0% per annum, payable semi-annually in arrears until maturity, and 2,000 common share purchase warrants of the Company (each, a “Warrant”). The Convertible Debentures will have a maturity date of 36 months from the date of issuance.

Each Convertible Debenture shall be convertible into common shares in the capital of the Company (each, a “Conversion Share”) at a price of $0.30 per Conversion Share.

Each Warrant entitles the holder thereof to acquire one common share in the capital of the Company (each, a “Warrant Share”) for an exercise price of $0.25 per Warrant Share for a period of 18 months following the closing date.

The Convertible Debentures are direct secured obligations of the Company and rank pari passu in right of payment of principal and interest with all other Convertible Debentures issued under the Offering.

The Company is pleased to announce that on November 6, 2019 it closed an initial tranche of 1,264 Units for gross proceeds of $1,264,000. These Units were purchased by one insider and existing shareholders. The Company intends to close the remaining Units in one or more tranches over the coming weeks.

Ryan Brown, the Chief Executive Officer, of the Company participated in the private placement and beneficially acquired 664 Units for a total proceeds of $664,000. The purchase constitutes a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The issuance is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of the Units issued to or the consideration paid by such insider did not exceed 25% of the Company’s market capitalization.

Certain finders (the “Finders”) received a cash commission on the sale of the Offering of $48,000. The Finders also received 48,000 compensation warrants (the “Compensation Warrants”), each carrying the right to purchase 3.3333 common shares in the capital of the Company at a price of $1.00 per Compensation Warrant for a period of 18 months from the closing date.

The proceeds of the Offering will be used by the Company for expansion of the Company’s facilities and for general corporate and working capital purposes.

The Convertible Debentures, Warrants and Compensation Warrants issued pursuant to the Offering and any common shares in the capital of the Company issued on conversion of the Convertible Debentures or exercise of the Warrants or Compensation Warrants are subject to a statutory hold period in Canada of four months and one day following the closing date in accordance with applicable securities laws, which shall expire on March 7, 2020. Additional resale restrictions may be applicable under the laws of other jurisdictions, if any.

The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities of the
Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Corporate Update
Since the submission of our evidence package to Health Canada, the Company has received some minor comments from the regulators all of which have been responded to within 24 hours. The Company will update shareholders with any material developments related to the application process.

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act.  The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has entered into agreements to acquire assets in California and Nevada.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements that include, but are not limited to, statements related to the intended use of proceeds from the Offering. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018, which is available under the issuer’s SEDAR profile at www.sedar.com. 

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected] 

Tags: , , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Announces Annual General and Special Meeting on December 16th and the Closing of the First Tranche of its Non-Brokered Private Placement of Secured Convertible Debenture Units $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

NORTHBUD $NBUD.ca – #Cannabis may be helping some #Canadians cope with #PTSD symptoms: study $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:30 AM on Wednesday, November 6th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

Cannabis may be helping some Canadians cope with PTSD symptoms: study

  • Cannabis use could be helping Canadians cope with some of the effects of post-traumatic stress disorder, according to new research from the BC Centre on Substance Use and University of British Columbia. 

By: Jeremiah Rodriguez

Cannabis use could be helping Canadians cope with some of the effects of post-traumatic stress disorder, according to new research from the BC Centre on Substance Use and University of British Columbia. 

Cannabis use could be helping Canadians alleviate some of the effects of post-traumatic stress disorder, according to new research from the BC Centre on Substance Use and University of British Columbia.

The study, published in the Journal of Psychopharmacology, found people with PTSD who were not using cannabis were “far more likely” to have suicidal thoughts and suffer from severe depression than self-proclaimed pot users, according to data taken from Statistics Canada’s 2012 Canadian Community Health Survey – Mental Health.

People who suffered trauma — including survivors of acute injury, violence, conflict and disasters — suffer at disproportionately higher rates of depression, suicide and substance abuse than the general population.

The research team found that among non-cannabis users, PTSD was “significantly associated” with a major recent depressive episode and suicidal thoughts.

More specifically, PTSD sufferers who didn’t use pot were seven times more likely to have a depressive episode and nearly five times more likely to have suicidal thoughts compared to non-cannabis users without PTSD.

“Among the cannabis-non-using population, there was a strong association between having PTSD and experiencing these indicators of severe mental distress,” lead author Stephanie Lake said during a phone interview with CTVNews.ca, adding that pot users didn’t see this same association.

Her research was the first to track the relationship between PTSD, cannabis use and “severe mental health outcomes” among the average Canadian population, according to a university press release.

Lake, a research assistant at the British Columbia Centre on Substance Use, said this was the first study examining how PTSD’s connection to suicidal thoughts or severe depression “could be interrupted by the use of cannabis.”

Her study also found one in four Canadians with PTSD said they used cannabis — which is “remarkably high” compared to the prevalence of pot use among the general Canadian population (which is an estimated 11.4 per cent).

STUDY DIDN’T SHOW CAUSAL LINK BETWEEN POT, PTSD RATES

Lake stressed her study didn’t outright show a definitive, causal link between cannabis use and decreased PTSD symptoms.

The PhD candidate at UBC’s School of Population and Public Health said the study “didn’t tell us whether people are successfully using cannabis to treat PTSD … but it is a promising signal that there might be a therapeutic (benefit) to cannabis use.”

Of the 24,089 respondents to the 2012 Canadian Community Health Survey – Mental Health, 420 people had a clinical diagnosis of PTSD.

From those with PTSD, 106 of them — 28 per cent — said they used cannabis. This rate is nearly three times the rate of pot users without PTSD (11.2 per cent).

Lake’s overall findings could be extremely helpful to many Canadians, as the study mentions that 9.2 per cent of Canadians have PTSD — one of the highest prevalence rates for the disorder in the world.

HOW CANNABIS POTENTIALLY HELPED WITH PTSD

Lake explained that cannabinoid receptors in people’s bodies help regulate mood and sleep, and some research suggests that trauma from PTSD could compromise this endocannabinoid system.

“So when you introduce external cannabinoids (from pot products) to the body, it might help to get the system working as normal again,” she suggested.

Lake also noted that, according to the study, PTSD patients did have cannabis-use disorders at a higher rate than the general population.

In a press release, senior author Dr. M-J Milloy, BCCSU research scientist and Canopy Growth Professor of Cannabis Science at UBC, said that “we’re only just beginning to understand what the therapeutic potential of cannabis may be for a variety of health conditions.”

“These findings are promising, and merit further study in order to fully understand the benefits of cannabis for people living with PTSD,” he added.

Lake added that UCB researchers are currently conducting a clinical trial looking at the effectiveness of cannabis products in specifically treating PTSD.

Source: https://www.theloop.ca/ctvnews/cannabis-may-be-helping-some-canadians-cope-with-ptsd-symptoms-study/

Tags: , , , , , , , ,
Posted in Featured, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – #Cannabis may be helping some #Canadians cope with #PTSD symptoms: study $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

« Older Entries
Newer Entries »